{"id":"W4324030589","doi":"10.1016/s0140-6736(23)00085-5","title":"Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study","year":2023,"lang":"en","type":"article","venue":"The Lancet","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":244,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Vasomotor; Medicine; Placebo; Menopause; Clinical trial; Randomized controlled trial; Physical therapy; Internal medicine; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006375455,0.0002994188,0.001901573,0.0001121366,0.0001748279,0.00002524591,0.0001211836,0.00005472352,0.00004614476],"category_scores_gemma":[0.0002889181,0.0001359788,0.00004382413,0.0003534975,0.00003089756,0.00003498192,0.00001574432,0.00005156911,0.00002526489],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001921787,"about_ca_system_score_gemma":0.0001919003,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006153348,"about_ca_topic_score_gemma":0.00006443812,"domain_scores_codex":[0.9980838,0.0001768968,0.0005031836,0.0002997156,0.0003510691,0.0005853063],"domain_scores_gemma":[0.997965,0.0007106048,0.0002541784,0.0006250273,0.0001747203,0.0002704459],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9531371,0.01116493,0.00398834,0.0001744776,0.01030615,0.0002809574,0.005831686,0.0002736444,0.008092456,0.00004472676,0.004369692,0.002335845],"study_design_scores_gemma":[0.9309338,0.05737307,0.004141615,0.0001650096,0.002539782,0.00001061286,0.0001484152,0.002654441,0.001175103,0.00004925457,0.0006392204,0.0001696257],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9816033,0.0001586556,0.00004335922,0.002347982,0.00009141158,0.0149617,0.0003649327,0.000145648,0.0002829934],"genre_scores_gemma":[0.9941366,0.00007179406,0.00008436522,0.0004714153,0.0002477258,0.002339787,0.0001499162,0.00005071808,0.002447706],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04620814,"threshold_uncertainty_score":0.5545056,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05924229414364834,"score_gpt":0.3621047316138458,"score_spread":0.3028624374701975,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}